Lead Story Picture

Auto Parts Co. To Pay $52M Fine In Price-Fixing Probe

The U.S. Department of Justice's ongoing antitrust probe of the auto parts industry barreled ahead on Tuesday as the agency announced that parts manufacturer NGK Spark Plug Co. Ltd. agreed to plead guilty for price-fixing and bid-rigging and pay a $52.1 million criminal fine.

  • Lawsky Bares Teeth With Latest Standard Chartered Penalty

    With Tuesday's latest penalty for Standard Chartered PLC over anti-money laundering violations, New York Superintendent of Financial Services Benjamin Lawsky is proving himself to be as feared an enforcer as his federal counterparts — if not even more so.

  • AstraZeneca Says DOJ Closing Probe Into Brilinta Trial

    U.K. pharmaceutical giant AstraZeneca PLC said on Tuesday that it has received confirmation from the U.S. Department of Justice that it is closing its investigation into a clinical trial for the company’s heart drug Brilinta.

  • Standard Chartered To Pay $300M For Fraud Control Failures

    New York’s financial regulator on Tuesday ordered Standard Chartered PLC to pay an additional $300 million and put a stop to some dollar-clearing businesses based out of Asia and the Middle East after a monitor found the British bank had not met standards set in an earlier sanctions violation settlement.

  • Goldman, Deutsche Escape $2.1B Guaranty Bank MBS Suit

    Goldman Sachs & Co.,  Deutsche Bank Securities Inc. and several other banks on Monday dodged the remnants of a lawsuit brought in Texas federal court by the Federal Deposit Insurance Corp. on behalf of defunct Guaranty Bank, which alleged it paid $2.1 billion to acquire 20 shoddy mortgage-backed securities from the banks

  • Medtronic Reaffirms $43B Covidien Bid Depsite Opposition

    Medical device maker Medtronic Inc. said Tuesday it is “fully committed” to proceeding with its $42.9 billion acquisition of rival Covidien PLC even as the controversial plan, which would shift company headquarters overseas where taxes are lower, faces scrutiny from U.S. legislators, regulators and shareholders.